NASDAQ:ENSC | Free Cash Flow | Ensysce Biosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.5M
2025-12-31-$1.53M$0.00-$1.53M
2025-03-31-$1.71M
2024-12-31-$764,090.00
2024-03-31-$3.41M
2023-12-31-$1.8M
2023-03-31-$3.61M
2022-12-31-$3.3M
2022-03-31-$3.44M
2021-12-31-$3.77M
2021-03-31-$517,149.00
2020-12-31-$533,857.00
2020-03-31-$234,388.00
2019-12-31-$425,756.00
2019-03-31-$294,366.00
2018-12-31-$458,641.00
2018-03-31-$216,827.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$7.81M$123,643.00-$7.93M
2024-12-31-$7.5M
2023-12-31-$10.78M
2022-12-31-$17.89M
2021-12-31-$8.24M
2020-12-31-$1.25M
2019-12-31-$1.42M
2018-12-31-$1.24M